BioHarvest Sciences (BHST) Expected to Announce Quarterly Earnings on Thursday

BioHarvest Sciences (NASDAQ:BHST) is projected to announce its Q3 2025 results after the market closes on Thursday, November 13th. Analysts expect the company to announce earnings of ($0.14) per share and revenue of $9.1110 million for the quarter. Interested persons may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Thursday, November 13, 2025 at 4:30 PM ET.

BioHarvest Sciences (NASDAQ:BHST) last issued its quarterly earnings data on Monday, August 11th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.04). BioHarvest Sciences had a negative net margin of 39.95% and a negative return on equity of 11,357.84%. The company had revenue of $8.52 million for the quarter, compared to the consensus estimate of $8.53 million. On average, analysts expect BioHarvest Sciences to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

BioHarvest Sciences Price Performance

BHST stock opened at $6.88 on Wednesday. The business has a fifty day moving average price of $9.69 and a 200 day moving average price of $8.12. BioHarvest Sciences has a fifty-two week low of $4.72 and a fifty-two week high of $12.80. The stock has a market capitalization of $112.97 million, a price-to-earnings ratio of -9.83 and a beta of 0.76.

Wall Street Analyst Weigh In

BHST has been the topic of a number of recent research reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of BioHarvest Sciences in a research note on Wednesday, October 8th. Wall Street Zen raised BioHarvest Sciences to a “hold” rating in a research note on Saturday, October 18th. Three analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, BioHarvest Sciences has an average rating of “Moderate Buy” and a consensus target price of $13.67.

BioHarvest Sciences Company Profile

BioHarvest Sciences Inc is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications.